News

Scientists have developed a new approach to study Sars-CoV-2. For systematic and standardized research of Sars-CoV-2 they built minimalistic synthetic virus particles where they can incorporate distinct structures of the Sars-CoV-2 virus like the spike protein.

Researchers have used sound waves to turn stem cells into bone cells, in a tissue engineering advance that could one day help patients regrow bone lost to cancer or degenerative disease.

Analysis of 60 billion tweets has shown that social media can form an echo chamber contributing to vaccine hesitancy.

Researchers have highlighted a specific gene that drives vision impairment, and have suggested that suppressing the protein encoded by this gene may be an avenue for treating genetic blindness.

Researchers have developed a new type of cholera vaccine consisting of polysaccharides displayed on virus-like particles. The vaccine generated long-lasting antibody responses against V. cholerae in mice.

A new study by researchers suggests that infusion of new, healthy hematopoietic stem and progenitor cells from the bone marrow could improve sepsis outcomes in a mouse model.

Artificial intelligence models are being used to analyze mutations to SARS-CoV-2, predicting that mutations that increase infectivity drive virus evolution, but in vaccinated populations, mutations enabling escape from vaccines are becoming dominant.

New findings show that messenger RNA can be used at low doses to regenerate bone without side effects. Moreover, the quality of the new bone is superior to bone formed by BMP-2, a treatment already approved by the FDA.

Antibodies elicited by COVID-19 vaccination become steadily more powerful for at least six months after vaccination, according to a new study. The research was conducted using the Pfizer–BioNTech COVID-19 vaccine.

A HIV patient who received a cord blood stem cell transplant to treat leukemia has been reported to have had no detectable levels of HIV for 14 months.